15-Lipoxygenase-1 induces lipid peroxidation and apoptosis, and improves survival in rat malignant glioma

In Vivo

Volumn 26, Issue 1, 2012, Pages 1-8

  Viita, Helena ^a   Pacholska, Agnieszka ^a   Ahmad, Farizan ^a   Tietäväinen, Johanna ^a   Naarala, Jonne ^a   Hyvärinen, Anna ^a,b   Wirth, Thomas ^a   Ylä Herttuala, Seppo ^a,c  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b NORTH KARELIA CENTRAL HOSPITAL   (Finland)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

15 Lipoxygenase 1; Apoptosis; Caspase 3; Gene therapy; Glioma; Lipid peroxidation

Indexed keywords

ADENOVIRUS VECTOR; ARACHIDONATE 15 LIPOXYGENASE; ARACHIDONATE 15 LIPOXYGENASE 1; CASPASE 3; CORIOLIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER GENE THERAPY; CANCER MODEL; CANCER SURVIVAL; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; GENETIC TRANSDUCTION; GLIOBLASTOMA; LIPID PEROXIDATION; LIVER; MACROPHAGE; MALE; MOUSE; NONHUMAN; NORTHERN BLOTTING; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; RAT; SPLEEN; TUMOR VOLUME; VIRAL GENE DELIVERY SYSTEM;

EID: 84855399788     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Kuhn H, Walther M and Kuban RJ: Mammalian arachidonate 15-lipoxygenases structure, function, and biological implications. Prostaglandins Other Lipid Mediat 68-69: 263-290, 2002. (Pubitemid 35247401)
2. Chanez P, Bonnans C, Chavis C and Vachier I: 15-Lipoxygenase: a Janus enzyme? Am J Respir Cell Mol Biol 27: 655-658, 2002. (Pubitemid 35381173)
3. Kühn H, Barnett J, Grunberger D, Baecker P, Chow J, Nguyen B, Bursztyn-Pettegrew H, Chan H and Sigal E: Overexpression, purification and characterization of human recombinant 15-lipoxygenase. Biochim Biophys Acta 1169: 80-89, 1993. (Pubitemid 23214246)
4. Brock TG and Peters-Golden M: Activation and regulation of cellular eicosanoid biosynthesis. ScientificWorldJournal 7: 1273-1284, 2007. (Pubitemid 47435440)
5. Kroschwald P, Kroschwald A, Kühn H, Ludwig P, Thiele BJ, Höhne M, Schewe T and Rapoport SM: Occurrence of the erythroid cell-specific arachidonate 15-lipoxygenase in human reticulocytes. Biochem Biophys Res Commun 160: 954-960, 1989. (Pubitemid 19140609)
6. Cathcart MK and Folcik VA: Lipoxygenases and atherosclerosis: protection versus pathogenesis. Free Radic Biol Med 28: 1726-1734, 2000. (Pubitemid 30628659)
7. Viita H and Ylä-Herttuala S: Effects of lipoxygenases on gene expression in mammalian cells. In: Antioxidant and Redox Regulation of Genes. Sen CK, Sies H and Baeuerle PA (eds.). San Diego, CA, USA, Academic Press, pp. 339-358, 2000.
8. Shureiqi I and Lippman SM: Lipoxygenase modulation to reverse carcinogenesis. Cancer Res 61: 6307-6312, 2001. (Pubitemid 32783228)
9. Hsi LC, Xi X, Lotan R, Shureiqi I and Lippman SM: The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces apoptosis via induction of 15-lipoxygenase-1 in colorectal cancer cells. Cancer Res 64: 8778-8781, 2004. (Pubitemid 39552097)
10. Hsi LC, Xi X, Wu Y and Lippman SM: The methyltransferase inhibitor 5-aza-2-deoxycytidine induces apoptosis via induction of 15-lipoxygenase-1 in colorectal cancer cells. Mol Cancer Ther 4: 1740-1746, 2005. (Pubitemid 41685308)
11. Shureiqi I, Jiang W, Zuo X, Wu Y, Stimmel JB, Leesnitzer LM, Morris JS, Fan HZ, Fischer SM and Lippman SM: The 15-lipoxygenase-1 product 13-S-hydroxyoctadecadienoic acid down-regulates PPAR-δ to induce apoptosis in colorectal cancer cells. Proc Natl Acad Sci USA 100: 9968-9973, 2003. (Pubitemid 37087052)
12. Nixon JB, Kim KS, Lamb PW, Bottone FG and Eling TE: 15-Lipoxygenase-1 has anti-tumorigenic effects in colorectal cancer. Prostaglandins Leukot Essent Fatty Acids 70: 7-15, 2004. (Pubitemid 38021636)
13. Wu Y, Fang B, Yang XQ, Wang L, Chen D, Krasnykh V, Carter BZ, Morris JS and Shureiqi I: Therapeutic molecular targeting of 15-lipoxygenase-1 in colon cancer. Mol Ther 16: 886-892, 2008. (Pubitemid 351587098)
14. Harats D, Ben-Shushan D, Cohen H, Gonen A, Barshack I, Goldberg I, Greenberger S, Hodish I, Harari A, Varda-Bloom N, Levanon K, Grossman E, Chaitidis P, Kühn H and Shaish A: Inhibition of carcinogenesis in transgenic mouse models over-expressing 15-lipoxygenase in the vascular wall under the control of murine preproendothelin-1 promoter. Cancer Lett 229: 127-134, 2005. (Pubitemid 41262549)
15. Viita H, Markkanen J, Eriksson E, Nurminen M, Kinnunen K, Babu M, Heikura T, Turpeinen S, Laidinen S, Takalo T and Yla-Herttuala S: 15-Lipoxygenase-1 prevents vascular endothelial growth factor A- and placental growth factor-induced angiogenic effects in rabbit skeletal muscles via reduction in growth factor mRNA levels, NO bioactivity, and down-regulation of VEGF receptor 2 expression. Circ Res 102: 177-184, 2008. (Pubitemid 351651121)
16. Laitinen M, Mäkinen K, Manninen H, Matsi P, Kossila M, Agrawal RS, Pakkanen T, Luoma JS, Viita H, Hartikainen J, Alhava E, Laakso M and Ylä-Herttuala S: Adenovirus-mediated gene transfer to lower limb artery of patients with chronic critical leg ischemia. Hum Gene Ther 9: 1481-1486, 1998. (Pubitemid 28379087)
17. Viita H, Sen CK, Roy S, Siljamäki T, Nikkari T and Ylä-Herttuala S: High expression of human 15-lipoxygenase induces NF-κB-mediated expression of vascular cell adhesion molecule 1, intercellular adhesion molecule 1, and T-cell adhesion on human endothelial cells. Antioxid Redox Signal 1: 83-96, 1999. (Pubitemid 129619765)
18. Sendobry SM, Comicelli JA, Welch K, Bocan T, Tait B, Trivedi BK, Colbry N, Dyer RD, Feinmark SJ and Daugherty A: Attenuation of diet-induced atherosclerosis in rabbits with a highly selective 15-lipoxygenase inhibitor lacking significant antioxidant properties. Br J Pharmacol 120: 1199-1206, 1997. (Pubitemid 27149668)
19. Bocan TM, Rosebury WS, Mueller SB, Kuchera S, Welch K, Daugherty A and Cornicelli JA: A specific 15-lipoxygenase inhibitor limits the progression and monocyte-macrophage enrichment of hypercholesterolemia-induced atherosclerosis in the rabbit. Atherosclerosis 136: 203-216, 1998. (Pubitemid 28133408)
20. Ishibashi S, Brown MS, Goldstein JL, Gerard RD, Hammer RE and Herz J: Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clin Invest 92: 883-893, 1993. (Pubitemid 23262411)
21. Suzuki H, Kurihara Y, Takeya M, Kamada N, Kataoka M, Jishage K, Ueda O, Sakaguchi H, Higashi T, Suzuki T, Takashima Y, Kawabe Y, Cynshi O, Wada Y, Honda M, Kurihara H, Aburatani H, Doi T, Matsumoto A, Azuma S, Noda T, Toyoda Y, Itakura H, Yazaki Y, Horiuchi S, Takahashi H, Kruijt JK, Van Berkel TJC, Steinbrecher UP, Ishibashi S, Maeda N, Gordon S and Kodama T: A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature 386: 292-296, 1997. (Pubitemid 27142516)
22. Jalkanen J, Leppänen P, Närvänen O, Greaves DR and Ylä-Herttuala S: Adenovirus-mediated gene transfer of a secreted decoy human macrophage scavenger receptor (SR-AI) in LDL receptor knock-out mice. Atherosclerosis 169: 95-103, 2003. (Pubitemid 36830927)
23. Sigal E, Grunberger D, Highland E, Gross C, Dixon RA and Craik CS: Expression of cloned human reticulocyte 15-lipoxygenase and immunological evidence that 15-lipoxygenases of different cell types are related. J Biol Chem 265: 5113-5120, 1990.
24. Ylä-Herttuala S, Rosenfeld ME, Parthasarathy S, Glass CK, Sigal E, Witztum JL and Steinberg D: Co-localization of 15-lipoxygenase mRNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions. Proc Natl Acad Sci USA 87: 6959-6963, 1990.
25. Pulkkanen KJ, Laukkanen MO, Naarala J and Yla-Herttuala S: False-positive apoptosis signal in mouse kidney and liver detected with TUNEL assay. Apoptosis 5: 329-333, 2000.
26. Sandmair AM, Loimas S, Poptani H, Vainio P, Vanninen R, Turunen M, Tyynelä K, Vapalahti M and Ylä-Herttuala S: Low efficacy of gene therapy for rat BT4C malignant glioma using intra-tumoural transduction with thymidine kinase retrovirus packaging cell injections and ganciclovir treatment. Acta Neurochir (Wien) 141: 867-72; discussion 872-3, 1999.
27. Nie D, Che M, Grignon D, Tang K and Honn KV: Role of eicosanoids in prostate cancer progression. Cancer Metastasis Rev 20: 195-206, 2001. (Pubitemid 34595268)
28. Shinoura N and Hamada H: Gene therapy using an adenovirus vector for apoptosis-related genes is a highly effective therapeutic modality for killing glioma cells. Curr Gene Ther 3: 147-153, 2003.
29. Kobayashi T, Masumoto J, Tada T, Nomiyama T, Hongo K and Nakayama J: Prognostic significance of the immunohistochemical staining of cleaved caspase-3, an activated form of caspase-3, in gliomas. Clin Cancer Res 13: 3868-3874, 2007. (Pubitemid 47037593)
30. Sandmair AM, Turunen M, Tyynelä K, Loimas S, Vainio P, Vanninen R, Vapalahti M, Bjerkvig R, Jänne J and Ylä-Herttuala S: Herpes simplex virus thymidine kinase gene therapy in experimental rat BT4C glioma model: effect of the percentage of thymidine kinase-positive glioma cells on treatment effect, survival time, and tissue reactions. Cancer Gene Ther 7: 413-421, 2000. (Pubitemid 30210408)
31. Norden AD, Drappatz J and Wen PY: Novel anti-angiogenic therapies for malignant gliomas. Lancet Neurol 7: 1152-1160, 2008.
32. Tsurushima H, Yuan X, Dillehay LE and Leong KW: Radio-responsive gene therapy for malignant glioma cells without the radiosensitive promoter: Caspase-3 gene therapy combined with radiation. Cancer Lett 246: 318-323, 2007. (Pubitemid 44959403)